Two decades ago, manufacturers launched patient support services to counter a distorted pharmaceutical supply chain - one designed for intermediaries, not patients, that shifts complexity and cost ...
Eli Lilly and Company announced a definitive agreement to acquire Aderum Biotechnologies and its leading candidate Ixo-vec. 1 ...
AI transforms pharmaceutical operations by automating workflows, ensuring transparency, and enhancing compliance, driving ...
In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug ...
PE: Could DTC programs help simplify the drug-pricing system? O’Dell: I’m guessing that the pharmaceutical manufacturers are ...
The DTC model aligns with Most-Favored-Nation pricing, aiming to close the US drug price gap with other high-income countries ...
Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...
Lynkuet is the first dual neurokinin receptor antagonist approved for moderate to severe VMS in menopause, offering a hormone-free treatment option. Phase III OASIS trials showed significant ...
GSK announced FDA’s approval of Blenrep in combination with bortezomib and dexamethasone (BVd) for the treatment of adults diagnosed with relapsed or refractory multiple myeloma who received a minimum ...
Innovent Biologics and Takeda announced a strategic global collaboration aiming to advance next-generation IO and ADC cancer ...
Elevara Medicines secured $70 million in Series A funding to advance ELV001's Phase II trial for rheumatoid arthritis and explore other chronic inflammatory conditions. Pharma investments surge as ...
Explore CEO insights on decision-making in manufacturing, focusing on risk management, packaging challenges, and strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback